Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Centessa Pharmaceuticals Plc (CNTA)  
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 87,420,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $ - $
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Centessa Pharmaceuticals is a pharmaceutical company that develops and delivers life-altering and life-enhancing medicines to patients. Co.'s product pipeline includes: Lixivaptan, a vasopressin V2 receptor small molecule inhibitor; SerpinPC, an activated protein C inhibitor for the treatment of hemophilia A and B; Imgatuzumab, an anti-EGFR monoclonal antibody for the treatment of cutaneous squamous cell carcinoma and for the treatment of other solid tumors in the context of combination treatment with immunotherapy; and ZF874, a small molecule chemical chaperone folding corrector of the Z variant of alpha-1-antitrypsin for the treatment of alpha-1-antitrypsin deficiency.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 10,000
Total Buy Value $0 $0 $0 $46,284
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 1
Total Shares Sold 51,160 55,427 107,411 368,796
Total Sell Value $607,960 $642,534 $943,036 $2,119,530
Total People Sold 1 2 4 10
Total Sell Transactions 1 2 5 35
End Date 2024-02-11 2023-11-10 2023-05-12 2022-05-12

   
Records found: 147
  Page 5 of 6  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Yver Antoine EVP & Chairman of Development   •       –      –    2022-07-01 4 S $5.03 $45,797 D/D (9,100) 730,597     -
   Bush Tia L Chief Quality Officer   •       –      –    2022-07-01 4 A $0.00 $0 D/D 140,000 140,000     -
   Chao David M Chief Administrative Officer   •       –      –    2022-07-01 4 A $0.00 $0 D/D 230,000 230,500     -
   Saha Saurabh Chief Executive Officer   •       •      –    2022-07-01 4 A $0.00 $0 D/D 750,000 750,000     -
   Grainger David J Chief Innovation Officer   •       –      –    2022-07-01 4 A $0.00 $0 D/D 100,000 913,756     -
   Saha Saurabh Chief Executive Officer   •       •      –    2022-06-24 4 B $4.63 $46,284 I/I 10,000 38,000 2.66     -
   Yver Antoine EVP & Chairman of Development   •       –      –    2022-06-17 4 S $4.68 $43,036 D/D (9,200) 739,697     -
   Yver Antoine EVP & Chairman of Development   •       –      –    2022-05-18 4 S $5.10 $330,102 D/D (64,778) 748,897     -
   Yver Antoine EVP & Chairman of Development   •       –      –    2022-05-17 4 S $5.42 $109,632 D/D (20,222) 813,675     -
   Thorell Marella Chief Accounting Officer   •       –      –    2022-03-21 4 A $0.00 $0 D/D 52,101 53,101     -
   Medicxi Secondary I Gp Ltd. 10% Owner   –       –       •   2022-03-21 4 A $0.00 $0 I/I 1,839,265 281,162     -
   De Rubertis Francesco Director   –       •      –    2022-03-21 4 A $0.00 $0 I/I 1,839,265 281,162     -
   Saha Saurabh Chief Executive Officer   •       •      –    2022-02-02 4 B $9.74 $48,700 I/I 5,000 28,000 2.66     -
   Grainger David J Chief Innovation Officer   •       –      –    2022-01-28 4 B $9.05 $248,754 I/I 27,500 27,500 1.99     -
   De Rubertis Francesco Director   –       •      –    2021-12-02 4 B $12.82 $440,059 I/I 34,326 93,526 2.1     -
   Medicxi Growth I Gp Ltd 10% Owner   –       –       •   2021-12-02 4 B $12.82 $440,059 I/I 34,326 93,526 1.5     -
   De Rubertis Francesco Director   –       •      –    2021-12-01 4 B $12.62 $761,036 I/I 60,304 92,730 2.1     -
   De Rubertis Francesco Director   –       •      –    2021-11-30 4 B $11.62 $428,162 I/I 36,847 91,331 2.1     -
   De Rubertis Francesco Director   –       •      –    2021-11-29 4 B $11.70 $663,477 I/I 56,706 90,476 2.1     -
   Medicxi Growth I Gp Ltd 10% Owner   –       –       •   2021-11-29 4 B $11.70 $663,477 I/I 56,706 90,476 1.5     -
   De Rubertis Francesco Director   –       •      –    2021-11-26 4 B $11.34 $133,949 I/I 11,817 89,161 2.1     -
   Medicxi Growth I Gp Ltd 10% Owner   –       –       •   2021-11-26 4 B $11.34 $133,949 I/I 11,817 89,161 1.5     -
   Kantoff Aaron Director   –       •      –    2021-11-18 4 B $11.99 $119,850 D/D 10,000 60,000 2.39     -
   Bush Tia L Chief Quality Officer   •       –      –    2021-11-16 4 B $12.10 $62,302 I/I 5,000 8,000 1.99     -
   Saha Saurabh Chief Executive Officer   •       •      –    2021-11-16 4 B $12.28 $282,472 I/I 23,000 23,000 2.66     -
  147 Records found
  1  2  3  4  5  6   
  Page 5 of 6
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us